Physician profile
Benjamin Ingenthron
NPI 1609465814
$1,578.65
in general payments reported to CMS, 2019-2025
6 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $302 · 2024: $1,102 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $757 · Food and Beverage: $737 · Education: $84.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $756.83 |
| Food and Beverage | $737.48 |
| Education | $84.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $829.68 | 2024 | Iovera |
| Medtronic, INC. | $473.02 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Zynex Medical, INC. | $227.86 | 2023 | Nexwave |
| Spr Therapeutics, INC | $16.77 | 2023 | Sprint Pns System |
| Xeris Pharmaceuticals, INC. | $15.81 | 2025 | Gvoke Hypopen |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.51 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Ingenthron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.